Michael Hochman, MD
Hematology · Atlanta, GANPI 1083145593
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,812 of the $6,252 with a category attached, or 61.0%. 8 manufacturers reported payments, led by Rigel Pharmaceuticals, Inc. at 59.0% of the total. Reporting peaked in 2024 at $5,702 and has fallen 93.8% since, to $351 in 2025. That places this record below the midpoint for hematology clinicians in GA, where the typical reported total is $6,392.
Across 24 payments — averaging $260.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rigel Pharmaceuticals, Inc.$4K
- Blueprint Medicines Corporation$2K
- Incyte Corporation$164
- AbbVie$122
- Stemline Therapeutics Inc.$104
- Sobi, Inc$84
- plus $116 from 2 others
Across 30 payments — averaging $61.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Daiichi Sankyo Inc.$2K
What the payments were for
- Speaking & faculty fees$3,81261%
- Travel & lodging$1,10718%
- Food & beverage$1,33321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 13 | $3,690 |
| Blueprint Medicines Corporation | 3 | $1,971 |
| Incyte Corporation | 3 | $164 |
| AbbVie | 1 | $122 |
| Stemline Therapeutics Inc. | 1 | $104 |
| Sobi, Inc | 1 | $84 |
| CTI Biopharma Corp. | 1 | $83 |
| Bristol Myers Squibb | 1 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,252 in reported general payments places this provider in the 45th percentile of 27 hematology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BesremiRopeginterferon Alfa-2b-Njft | 22 | $374,608 |
| JakafiRuxolitinib Phosphate | 19 | $332,127 |
| VenclextaVenetoclax | 26 | $150,625 |
| Tretinoin | 14 | $24,326 |
| Posaconazole | 17 | $22,265 |
| EliquisApixaban | 13 | $7,483 |
| Hydroxyurea | 35 | $1,855 |
| ValacyclovirValacyclovir Hcl | 27 | $1,372 |
| Potassium Chloride | 11 | $209 |
| Levofloxacin | 12 | $184 |
| Atorvastatin Calcium | 17 | $178 |
| Famotidine | 15 | $89 |
| Pantoprazole Sodium | 16 | $70 |
| Ondansetron Hcl | 12 | $55 |
| Furosemide | 12 | $3 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationJakafi | $164 | $332,12719 claims |
| AbbVieVenclexta | $122 | $150,62526 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 27 hematology providers in Georgia.
Other hematology in Atlanta
- Sagar LonialAtlanta$1.6M
- Edmund WallerAtlanta$119K
- Craig HofmeisterAtlanta$50K
- Lorraine CafuirAtlanta$41K
- Christine KemptonAtlanta$38K
- Manila GaddhAtlanta$37K
- Kenneth BraunsteinAtlanta$33K
- Duc TranAtlanta$32K
- Mary Jo LechowiczAtlanta$18K
- Martha ArellanoAtlanta$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.